Search

Savitha M. Rao

Examiner (ID: 10492, Phone: (571)270-5315 , Office: P/1621 )

Most Active Art Unit
1629
Art Unit(s)
1629, 1614, 1621, 1691, 4131
Total Applications
1525
Issued Applications
872
Pending Applications
108
Abandoned Applications
583

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7523112 [patent_doc_number] => 08026268 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-27 [patent_title] => 'Method for scavenging radicals with urocanic acid, derivatives and analogues' [patent_app_type] => utility [patent_app_number] => 11/289237 [patent_app_country] => US [patent_app_date] => 2005-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 8534 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/026/08026268.pdf [firstpage_image] =>[orig_patent_app_number] => 11289237 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/289237
Method for scavenging radicals with urocanic acid, derivatives and analogues Nov 28, 2005 Issued
Array ( [id] => 4827152 [patent_doc_number] => 20080125495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Ameliorant For Renal Insufficiency' [patent_app_type] => utility [patent_app_number] => 11/720125 [patent_app_country] => US [patent_app_date] => 2005-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2205 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20080125495.pdf [firstpage_image] =>[orig_patent_app_number] => 11720125 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/720125
Ameliorant For Renal Insufficiency Nov 24, 2005 Abandoned
Array ( [id] => 5095149 [patent_doc_number] => 20070116758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Atorvastatin formulation' [patent_app_type] => utility [patent_app_number] => 11/285961 [patent_app_country] => US [patent_app_date] => 2005-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5513 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20070116758.pdf [firstpage_image] =>[orig_patent_app_number] => 11285961 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/285961
Atorvastatin formulation Nov 22, 2005 Abandoned
Array ( [id] => 5546744 [patent_doc_number] => 20090156621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'HCV INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/719903 [patent_app_country] => US [patent_app_date] => 2005-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17190 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156621.pdf [firstpage_image] =>[orig_patent_app_number] => 11719903 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/719903
HCV INHIBITORS Nov 13, 2005 Abandoned
Array ( [id] => 4705236 [patent_doc_number] => 20080064760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'Spontaneously Dispersible Pharmaceutical Composition' [patent_app_type] => utility [patent_app_number] => 11/575203 [patent_app_country] => US [patent_app_date] => 2005-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7794 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064760.pdf [firstpage_image] =>[orig_patent_app_number] => 11575203 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/575203
Spontaneously Dispersible Pharmaceutical Composition Oct 26, 2005 Abandoned
Array ( [id] => 5807304 [patent_doc_number] => 20060093658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Apparatus and method for transdermal delivery of desmopressin' [patent_app_type] => utility [patent_app_number] => 11/259010 [patent_app_country] => US [patent_app_date] => 2005-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14811 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20060093658.pdf [firstpage_image] =>[orig_patent_app_number] => 11259010 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/259010
Apparatus and method for transdermal delivery of desmopressin Oct 24, 2005 Abandoned
Array ( [id] => 5386355 [patent_doc_number] => 20090227600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => '4-(PYRAZINE-2-YL) -PYRROLIDINE -2-CARBOXYLIC ACID COMPOUNDS AND DERIVATIVES THEREOF AS HEPATITIS C VIRUS INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/577940 [patent_app_country] => US [patent_app_date] => 2005-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18101 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227600.pdf [firstpage_image] =>[orig_patent_app_number] => 11577940 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/577940
4-(PYRAZINE-2-YL) -PYRROLIDINE -2-CARBOXYLIC ACID COMPOUNDS AND DERIVATIVES THEREOF AS HEPATITIS C VIRUS INHIBITORS Oct 23, 2005 Abandoned
Array ( [id] => 5912269 [patent_doc_number] => 20060127331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Moisturizing compositions' [patent_app_type] => utility [patent_app_number] => 11/251939 [patent_app_country] => US [patent_app_date] => 2005-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5612 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20060127331.pdf [firstpage_image] =>[orig_patent_app_number] => 11251939 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/251939
Moisturizing compositions Oct 17, 2005 Abandoned
Array ( [id] => 5747421 [patent_doc_number] => 20060110352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Cosmetic, pharmaceutical and dermatological compositions' [patent_app_type] => utility [patent_app_number] => 11/250756 [patent_app_country] => US [patent_app_date] => 2005-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15823 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20060110352.pdf [firstpage_image] =>[orig_patent_app_number] => 11250756 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/250756
Cosmetic, pharmaceutical and dermatological compositions Oct 13, 2005 Abandoned
Array ( [id] => 4711638 [patent_doc_number] => 20080300164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'Calixarene-Based Peptide Conformation Mimetics, Methods of Use, and Methods of Making' [patent_app_type] => utility [patent_app_number] => 11/664641 [patent_app_country] => US [patent_app_date] => 2005-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 32057 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20080300164.pdf [firstpage_image] =>[orig_patent_app_number] => 11664641 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/664641
Calixarene-based peptide conformation mimetics, methods of use, and methods of making Oct 3, 2005 Issued
Array ( [id] => 5171248 [patent_doc_number] => 20070071679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Methylamine risks and treatment of hyperactivity, depression, and alcoholism with epinephrine-N-quinolines' [patent_app_type] => utility [patent_app_number] => 11/248498 [patent_app_country] => US [patent_app_date] => 2005-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9889 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20070071679.pdf [firstpage_image] =>[orig_patent_app_number] => 11248498 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/248498
Methylamine risks and treatment of hyperactivity, depression, and alcoholism with epinephrine-N-quinolines Sep 28, 2005 Abandoned
Array ( [id] => 4752028 [patent_doc_number] => 20080160101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Composition For Use Against One Or More Pathogens' [patent_app_type] => utility [patent_app_number] => 11/663641 [patent_app_country] => US [patent_app_date] => 2005-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11077 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20080160101.pdf [firstpage_image] =>[orig_patent_app_number] => 11663641 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/663641
Compositions for use against one or more pathogens Sep 22, 2005 Issued
Array ( [id] => 4922641 [patent_doc_number] => 20080070958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'Therapeutic Agent for Keratoconjunctival Disorder' [patent_app_type] => utility [patent_app_number] => 11/662233 [patent_app_country] => US [patent_app_date] => 2005-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2369 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20080070958.pdf [firstpage_image] =>[orig_patent_app_number] => 11662233 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/662233
Therapeutic Agent for Keratoconjunctival Disorder Sep 12, 2005 Abandoned
Array ( [id] => 4670471 [patent_doc_number] => 20080045531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Anti-inflammatory medicaments' [patent_app_type] => utility [patent_app_number] => 11/224750 [patent_app_country] => US [patent_app_date] => 2005-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24449 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045531.pdf [firstpage_image] =>[orig_patent_app_number] => 11224750 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/224750
Anti-inflammatory medicaments Sep 11, 2005 Abandoned
Array ( [id] => 5148191 [patent_doc_number] => 20070048247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Deodorizing tablets' [patent_app_type] => utility [patent_app_number] => 11/217098 [patent_app_country] => US [patent_app_date] => 2005-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6627 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20070048247.pdf [firstpage_image] =>[orig_patent_app_number] => 11217098 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/217098
Deodorizing tablets Aug 30, 2005 Abandoned
Array ( [id] => 4999369 [patent_doc_number] => 20070042003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Method of effecting a mammalian model of sepsis, severe sepsis, or septic shock' [patent_app_type] => utility [patent_app_number] => 11/208143 [patent_app_country] => US [patent_app_date] => 2005-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11211 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20070042003.pdf [firstpage_image] =>[orig_patent_app_number] => 11208143 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/208143
Method of effecting a mammalian model of sepsis, severe sepsis, or septic shock Aug 18, 2005 Abandoned
Array ( [id] => 92332 [patent_doc_number] => 07732479 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Compositions for treating amyloid associated diseases' [patent_app_type] => utility [patent_app_number] => 11/660522 [patent_app_country] => US [patent_app_date] => 2005-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 13779 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732479.pdf [firstpage_image] =>[orig_patent_app_number] => 11660522 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/660522
Compositions for treating amyloid associated diseases Aug 17, 2005 Issued
Array ( [id] => 4887747 [patent_doc_number] => 20080262079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Cannabinoid Compositions and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/659751 [patent_app_country] => US [patent_app_date] => 2005-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5384 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20080262079.pdf [firstpage_image] =>[orig_patent_app_number] => 11659751 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/659751
Cannabinoid Compositions and Methods of Use Thereof Aug 8, 2005 Abandoned
Array ( [id] => 5050942 [patent_doc_number] => 20070031487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Nutritional supplement for women' [patent_app_type] => utility [patent_app_number] => 11/197760 [patent_app_country] => US [patent_app_date] => 2005-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2882 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20070031487.pdf [firstpage_image] =>[orig_patent_app_number] => 11197760 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/197760
Nutritional supplement for women Aug 3, 2005 Issued
Array ( [id] => 5820059 [patent_doc_number] => 20060024372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'High viscosity antibacterials' [patent_app_type] => utility [patent_app_number] => 11/194818 [patent_app_country] => US [patent_app_date] => 2005-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6902 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024372.pdf [firstpage_image] =>[orig_patent_app_number] => 11194818 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/194818
High viscosity antibacterials Jul 31, 2005 Abandoned
Menu